Literature DB >> 400740

Effect of age on fasting plasma levels of pancreatic hormones in man.

D Berger, R C Crowther, J C Floyd, S Pek, S S Fajans.   

Abstract

The effect of age and adiposity on fasting plasma levels of pancreatic polypeptide (HPP), glucagon (IRG), insulin (IRI) and glucose was examined in 263 healthy subjects between the ages of 20-69 yr. Mean plasma levels of hPP rose continuously from the third through the seventh decades. Mean plasma levels of IRG rose within the third and fourth decades but failed to rise further thereafter. Mean plasma levels of IRI did not change with age. Mean plasma levels of glucose rose by approximately 2 mg/dl . decade. The correlations of age with hPP, IRG, glucose, and adiposity were 0.47, 0.35, 0.25 (all P less than 0.01) and 0.15 (P less than 0.05), respectively. When adjustments were made for adiposity, the correlations of age with hPP, IRG, and glucose remained. Adiposity correlated with IRI, IRG, and glucose but when age correction was made, only the correlation of adiposity with IRI persisted. We conclude that: 1) age has a significant effect on fasting plasma levels of hPP and IRG; 2) the patterns of the age-related changes in hPP and IRG are not the same, suggesting that there are differences in the mechanism(s) by which age influences plasma levels of these two pancreatic hormones; and 3) age should be considered in the interpretation of fasting plasma levels of hPP and IRG.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 400740     DOI: 10.1210/jcem-47-6-1183

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.

Authors:  A V Greco; L Altomonte; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

Review 2.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 4. Tests involving the measurement of pancreatic enzymes in body fluid.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

3.  Glucose tolerance in two unacculturated Indian tribes of Brazil.

Authors:  R S Spielman; S S Fajans; J V Neel; S Pek; J C Floyd; W J Oliver
Journal:  Diabetologia       Date:  1982-08       Impact factor: 10.122

4.  Glucagon physiology and aging: evidence for enhanced hepatic sensitivity.

Authors:  D C Simonson; R A DeFronzo
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

Review 5.  Effects of age on various aspects of glucose and insulin metabolism.

Authors:  G M Reaven; E P Reaven
Journal:  Mol Cell Biochem       Date:  1980-05-28       Impact factor: 3.396

6.  Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Authors:  Atoosa Rabiee; Panagis Galiatsatos; Rocio Salas-Carrillo; Michael J Thompson; Dana K Andersen; Dariush Elahi
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

7.  Plasma human pancreatic polypeptide response in chronic pancreatitis.

Authors:  M Matsumoto; H Wakasugi; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1982

8.  The effect of treatment of type 2 (insulin independent) diabetes mellitus on plasma concentrations of pancreatic polypeptide and glucagon.

Authors:  D Berger; J C Floyd; S B Pek
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

Review 9.  Pancreatic polypeptide islet cell tumor: case report and review of the literature.

Authors:  C Bellows; S Haque; B Jaffe
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.267

10.  Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study.

Authors:  Steven E Kahn; Kieren J Mather; Silva A Arslanian; Elena Barengolts; Thomas A Buchanan; Sonia Caprio; David A Ehrmann; Tamara S Hannon; Santica Marcovina; Kristen J Nadeau; Kristina M Utzschneider; Anny H Xiang; Sharon L Edelstein
Journal:  Diabetes Care       Date:  2021-06-15       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.